Cargando…
Application and mechanism of anti-VEGF drugs in age-related macular degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly. The incidence rate increases with age in people over 50 years of age. With the advent of China’s aging society, the number of patients is increasing year by year. Although researchers have done a lot of basic re...
Autores principales: | Song, Dawei, Liu, Ping, Shang, Kai, Ma, YiBin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545772/ https://www.ncbi.nlm.nih.gov/pubmed/36213057 http://dx.doi.org/10.3389/fbioe.2022.943915 |
Ejemplares similares
-
Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy
por: Huang, Xi, et al.
Publicado: (2023) -
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part I: Biomaterials-Based Drug Delivery Devices
por: Jemni-Damer, Nahla, et al.
Publicado: (2020) -
Optimisation of a Novel Bio-Substrate as a Treatment for Atrophic Age-Related Macular Degeneration
por: McCormick, Rachel, et al.
Publicado: (2020) -
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies
por: Jemni-Damer, Nahla, et al.
Publicado: (2020) -
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
por: García-Quintanilla, Laura, et al.
Publicado: (2019)